UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000058387
Receipt number R000066754
Scientific Title Postoperative infection and prognosis in postoperative lung cancer: a systematic review and meta-analysis
Date of disclosure of the study information 2025/07/07
Last modified on 2025/07/07 14:28:14

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Postoperative infection and prognosis in postoperative lung cancer: a systematic review and meta-analysis

Acronym

Postoperative infection and prognosis in postoperative lung cancer: a systematic review and meta-analysis

Scientific Title

Postoperative infection and prognosis in postoperative lung cancer: a systematic review and meta-analysis

Scientific Title:Acronym

Postoperative infection and prognosis in postoperative lung cancer: a systematic review and meta-analysis

Region

Japan


Condition

Condition

lung cancer surgery patients

Classification by specialty

Chest surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate whether postoperative infection after lung cancer surgery is related to prognosis.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

5-year overall survival, 5-year cancer-specific survival

Key secondary outcomes



Base

Study type

Others,meta-analysis etc


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

(1) Comparison based on the presence or absence of postoperative infection (2) Focusing on lung cancer surgery

Key exclusion criteria

none

Target sample size

1000


Research contact person

Name of lead principal investigator

1st name Yuichiro
Middle name
Last name Machida

Organization

Nippon Medical School

Division name

Thoracic Surgery

Zip code

1138603

Address

1-1-5 Sendagi, Bunkyo, Tokyo, Japan

TEL

0333822131

Email

y-machida@nms.ac.jp


Public contact

Name of contact person

1st name Yuichiro
Middle name
Last name Machida

Organization

Nippon Medical School

Division name

Thoracic Surgery

Zip code

1138603

Address

1-1-5 Sendagi, Bunkyo, Tokyo, Japan

TEL

0338222131

Homepage URL


Email

y-machida@nms.ac.jp


Sponsor or person

Institute

Nippon Medical School

Institute

Department

Personal name

Yuichiro Machida


Funding Source

Organization

none

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nippon Medical School

Address

1-1-5 Sendagi, Bunkyo, Tokyo, Japan

Tel

0338222131

Email

y-machida@nms.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2025 Year 07 Month 07 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2025 Year 07 Month 07 Day

Date of IRB


Anticipated trial start date

2025 Year 07 Month 07 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

We systematically searched the literature using MEDLINE (via PubMed), the Cochrane Central Register of Controlled Trials (CENTRAL), Google Scholar, and ICHUSHI-Web, a Japanese database maintained by the Japan Medical Abstracts Society.


Management information

Registered date

2025 Year 07 Month 07 Day

Last modified on

2025 Year 07 Month 07 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066754